[1] Gold, L.S., N.B. Manley, T.H. Slone and L. Rohrbach, Supplement to the Carcinogenic Potency Database (CPDB): Results of Animal Bioassays Published in the General Literature in 1993-1994 and by the National Toxicology Program in 1995-1996, Environ. Health Perspect. 107 (Suppl. 4) (1999) 527-600.

[2] Ames, B.N. and L.S. Gold, Chemical carcinogenesis: Too many rodent carcinogens, Proc. Natl. Acad. Sci. USA 87 (1990) 7772-7776.

[3] Gold, L.S. and E. Zeiger (Eds.), Handbook of Carcinogenic Potency and Genotoxicity Databases, CRC Press, Boca Raton, FL, 1997.

[4] Heddle, J.A., The role of proliferation in the origin of mutations in mammalian cells, Drug Metab Rev 30 (1998) 327-38.

[5] Tombolan, F., D. Renault, D. Brault, M. Guffroy, F. Perin and V. Thybaud, Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTMMice treated with 5, 9- dimethyldibenzo[c,g]carbazole, Carcinogenesis 20 (1999) 1357-62.

[6] Cohen, S.M., Cell proliferation and carcinogenesis, Drug Metab Rev 30 (1998) 339-57.

[7] Butterworth, B.E. and M.S. Bogdanffy, A comprehensive approach for integration of toxicity and cancer risk assessments, Regul Toxicol Pharmacol 29 (1999) 23-36.

[8] Ames, B.N., M.K. Shigenaga and L.S. Gold, DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis, Environ. Health Perspect. 101(Suppl 5) (1993) 35-44.

[9] Gold, L.S., T.H. Slone and B.N. Ames, What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the Carcinogenic Potency Database, Drug Metab. Rev. 30 (1998) 359-404.

[10] Ames, B.N. and L.S. Gold, The prevention of cancer, Drug Metab. Rev. 30 (1998) 201-223.

[11] Song, K.Y., I.K. Lim, S.C. Park, S.O. Lee, H.S. Park, Y.K. Choi and B.H. Hyun, Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N- nitrosodiethylamine initiated hepatocarcinogenesis in the male fischer 344 rat, Carcinogenesis 20 (1999) 1541-8.

[12] Cunningham, M.L., Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens, Mutat Res 365 (1996) 59-69.

[13] Cunningham, M.L. and H.B. Matthews, Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs. carcinogens. II. 1- vs. 2-nitropropane, Toxicol. Appl. Pharmacol. 110 (1991) 505-513.

[14] Cunningham, M.L., J. Foley, R. Maronpot and H.B. Matthews, Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen: Carcinogen pair--2,6-and 2,4-diaminotoluene, Toxicol. Appl. Pharmacol. 107 (1991) 562-567.

[15] Christensen, J.G., T.L. Goldsworthy and R.C. Cattley, Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens, Mol Carcinog 25 (1999) 273-84.

[16] Hill, L.L., A. Ouhtit, S.M. Loughlin, M.L. Kripke, H.N. Ananthaswamy and L.B. Owen-Schaub, Fas ligand: a sensor for DNA damage critical in skin cancer etiology, Science 285 (1999) 898-900.

[17] Helbock, H.J., K.B. Beckman, M.K. Shigenaga, P. Walter, A.A. Woodall, H.C. Yeo and B.N. Ames, DNA oxidation matters: The HPLC-EC assay of 8-oxo-deoxyguanosine and 8-oxo-guanine, Proc. Natl. Acad. Sci. USA 95 (1998) 288-293.

[18] Laskin, D.L. and K.J. Pendino, Macrophages and inflammatory mediators in tissue injury, Annu. Rev. Pharmacol. Toxicol. 35 (1995) 655-677.

[19] Wei, H. and K. Frenkel, Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters, Carcinogenesis 14 (1993) 1195-1201.

[20] Wei, L., H. Wei and K. Frenkel, Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage, Carcinogenesis 14 (1993) 841-847.

[21] Laskin, D.L., F.M. Robertson, A.M. Pilaro and J.D. Laskin, Activation of liver macrophages following phenobarbital treatment of rats, Hepatology 8 (1988) 1051-1055.

[22] Adachi, Y., L.E. Moore, B.U. Bradford, W. Gao and R.G. Thurman, Antibiotics prevent liver injury in rats following long-term exposure to ethanol, Gastroenterology 108 (1995) 218-224.

[23] Gunawardhana, L., S.A. Mobley and I.G. Sipes, Modulation of 1,2-dichlorobenzene hepatotoxicity in the Fischer-344 rat by a scavenger of superoxide anions and an inhibitor of Kupffer cells, Toxicol. Appl. Pharmacol. 119 (1993) 205-213.

[24] Roberts, R.A. and I. Kimber, Cytokines in non-genotoxic hepatocarcinogenesis, Carcinogenesis 20 (1999) 1397-402.

[25] Czaja, M.J., J. Xu, Y. Ju, E. Alt and P. Schmiedeberg, Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration, Hepatology 19 (1994) 1282-1289.

[26] Omenn, G.S., S. Stuebbe and L.B. Lave, Predictions of rodent carcinogenicity testing results: interpretation in light of the Lave-Omenn value-of-information model, Mol. Carcinog. 14 (1995) 37-45.

[27] Butterworth, B., R. Conolly and K. Morgan, A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessment, Cancer Lett. 93 (1995) 129-146.

[28] Gaylor, D.W. and L. Swirsky Gold, Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose, Regul Toxicol Pharmacol 28 (1998) 222-5.

[29] Munday, R. and C.M. Munday, Low doses of diallyl disulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat, Nutr Cancer 34 (1999) 42-8.

[30] Trosko, J.E., Hierarchical and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposures to oxidative stress-inducing agents, Environ Health Perspect 106 Suppl 1 (1998) 331-9.

[31] Luckey, T.D., Nurture with ionizing radiation: a provocative hypothesis, Nutr Cancer 34 (1999) 1-11.

[32] Ames, B.N., M. Profet and L.S. Gold, Nature's chemicals and synthetic chemicals: Comparative toxicology, Proc. Natl. Acad. Sci. USA 87 (1990) 7782-7786.

[33] Ames, B.N., M. Profet and L.S. Gold, Dietary pesticides (99.99% all natural), Proc. Natl. Acad. Sci. USA 87 (1990) 7777-7781.

[34] Gold, L.S., T.H. Slone and B.N. Ames, Prioritization of possible carcinogenic hazards in food, in: D. Tennant (Ed.), Food Chemical Risk Analysis, Chapman & Hall Ltd, London, 1997, pp. 267-295.

[35] Gold, L.S., T.H. Slone, B.R. Stern, N.B. Manley and B.N. Ames, Rodent carcinogens: Setting priorities, Science 258 (1992) 261-265.

[36] Ames, B.N., R. Magaw and L.S. Gold, Ranking possible carcinogenic hazards, Science 236 (1987) 271-280.

[37] Gold, L.S., T.H. Slone and B.N. Ames, Overview and update analyses of the carcinogenic potency database, in: L.S. Gold and E. Zeiger (Eds.), Handbook of Carcinogenic Potency and Genotoxicity Databases, CRC Press, Boca Raton, FL, 1997, pp. 661-685.

[38] Gold, L.S., G.B. Garfinkel and T.H. Slone, Setting priorities among possible carcinogenic hazards in the workplace, in: C.M. Smith, D.C. Christiani and K.T. Kelsey (Eds.), Chemical Risk Assessment and Occupational Health, Current Applications, Limitations, and Future Prospects, Greenwood Publishing Group, Westport, CT, 1994, pp. 91-103.

[39] National Research Council, Carcinogens and Anticarcinogens in the Human Diet: A Comparison of Naturally Occurring and Synthetic Substances, National Academy Press, Washington, D.C., 1996.

[40] Ames, B.N., L.S. Gold and M.K. Shigenaga, Cancer prevention, rodent high-dose cancer tests and risk assessment, Risk Anal. 16 (1996) 613-617.

[41] National Academy of Sciences, U.S.A., The Life Sciences: Recent Progress and Application to Human Affairs, the World of Biological Research, Requirement for the Future, Committee on Research in the Life Sciences, Washington, D.C., 1970, pp. 526 p.

[42] Gribble, G.W., The diversity of natural organochlorines in living organisms, Pure Appl. Chem. 68 (1996) 1699-1712.

[43] Xie, B., S.W. Tsao and Y.C. Wong, Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens, Carcinogenesis 20 (1999) 1597-606.

[44] Henderson, B.E., R.K. Ross and M.C. Pike, Toward the primary prevention of cancer, Science 254 (1991) 1131-1138.

[45] Ames, B.N., Micronutrients prevent cancer and delay aging, Toxicol. Lett. 102-103 (1998) 5-18.

[46] Ames, B.N., L.S. Gold and W.C. Willett, The causes and prevention of cancer, Proc. Natl. Acad. Sci. USA 92 (1995) 5258-5265.

[47] Christen, S., T.M. Hagen, M.K. Shigenaga and B.N. Ames, Chronic inflammation, mutation, and cancer, in: J. Parsonnet and S. Hornig (Eds.), Microbes and Malignancy: Infection as a Cause of Cancer, Oxford University Press, New York, 1999, pp. 35-88.

[48] Ames, B.N., M.K. Shigenaga and T.M. Hagen, Oxidants, antioxidants, and the degenerative diseases of aging, Proc. Natl. Acad. Sci. USA 90 (1993) 7915-7922.

[49] Block, G., B. Patterson and A. Subar, Fruit, vegetables and cancer prevention: A review of the epidemiologic evidence, Nutr. Cancer 18 (1992) 1-29.

[50] Steinmetz, K.A. and J.D. Potter, Vegetables, fruit, and cancer prevention: A review, J. Am. Diet Assoc. 96 (1996) 1027-1039.

[51] Hill, M.J., A. Giacosa and C.P.J. Caygill, Epidemiology of Diet and Cancer, Ellis Horwood Series in Food Science and Technology, Ellis Horwood Limited, West Sussex, England, 1994.

[52] Krebs-Smith, S.M., A. Cook, A.F. Subar, L. Cleveland, J. Friday and L.L. Kahle, Fruit and vegetable intakes of children and adolescents in the United States, Arch. Pediatr. Adolesc. Med. 150 (1996) 81-86.

[53] Krebs-Smith, S.M., A. Cook, A.F. Subar, L. Cleveland and J. Friday, US adults' fruit and vegetable intakes, 1989 to 1991: A revised baseline for the healthy people 2000 objective, Am. J. Public Health 85 (1995) 1623-1629.

[54] National Cancer Institute Graphic, Why eat five?, J. Natl. Cancer Inst. 88 (1996) 1314.

[55] Blount, B.C., M.M. Mack, C. Wehr, J. MacGregor, R. Hiatt, G. Wang, S.N. Wickramasinghe, R.B. Everson and B.N. Ames, Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage., Proc. Natl. Acad. Sci. USA 94 (1997) 3290-3295.

[56] Fenech, M., C. Aitken and J. Rinaldi, Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults, Carcinogenesis 19 (1998) 1163-1171.

[57] Giovannucci, E., M.J. Stampfer, G.A. Colditz, E.B. Rimm, D. Trichopoulos, B.A. Rosner, F.E. Speizer and W.C. Willett, Folate, methionine, and alcohol intake and risk of colorectal adenoma, J. Natl. Cancer Inst. 85 (1993) 875-884.

[58] Mason, J.B., Folate and colonic carcinogenesis: Searching for a mechanistic understanding, J. Nutr. Biochem. 5 (1994) 170-175.

[59] Giovannucci, E., Stampfer, M. J., Colditz, G. A., Hunger, D. J., Fuchs, C., Rosner, B. A., Speizer, F. E., Willett, W. C., Multivitamin use, folate, and colon cancer in women in the nurses' health study, Ann. Intern. Med. 129 (1998) 517-524.

[60] Wallock, L., A. Woodall, R. Jacob and B. Ames, Nutritional status and positive relation of plasma folate to fertility indices in nonsmoking men [abstract], FASEB J. 11 (1997) A184 -1068.

[61] Boushey, C.J., S.A. Beresford, G.S. Omenn and A.G. Motulsky, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, J. Am. Med. Assoc. 274 (1995) 1049-1057.

[62] Subar, A.F., G. Block and L.D. James, Folate intake and food sources in the US population, Am. J. Clin. Nutr. 50 (1989) 508-516.

[63] Senti, F.R. and S.M. Pilch, Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II), J. Nutr. 115 (1985) 1398-1402.

[64] Bailey, L.B., P.A. Wagner, G.J. Christakis, P.E. Araujo, H. Appledorf, C.G. Davis, J. Masteryanni and J.S. Dinning, Folacin and iron status and hematological findings in predominately black elderly persons from urban low-income households, Am. J. Clin. Nutr. 32 (1979) 2346-2353.

[65] Bailey, L.B., P.A. Wagner, G.J. Christakis, C.G. Davis, H. Appledorf, P.E. Araujo, E. Dorsey and J.S. Dinning, Folacin and iron status and hematological findings in black and Spanish-American adolescents from urban low-income households, Am. J. Clin. Nutr. 35 (1982) 1023-1032.

[66] Jacques, P.F., J. Selhub, A.G. Bostom, P.W. Wilson and I.H. Rosenberg, The effect of folic acid fortification on plasma folate and total homocysteine concentrations, N Engl J Med 340 (1999) 1449-54.

[67] Wilson, J.W., C.W. Enns, J.D. Goldman, K.S. Tippett, S.J. Mickle, L.E. Cleveland and P.S. Chahil, Data tables: Combined results from USDA's 1994 and 1995 continuing survey of food intakes by individuals and 1994 and 1995 diet and health knowledge survey, USDA/ARS Food Surveys Research Group, Beltsville Human Nutrition Research Center, Riverdale, MD, 1997.

[68] van Asselt, D.Z., L.C. de Groot, W.A. van Staveren, B.H. J, R.A. Wevers, I. Biemond and W.H. Hoefnagels, Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects, Am. J. Clin. Nutr. 68 (1998) 328-334.

[69] Oakley, G.P., Jr., M.J. Adams and C.M. Dickinson, More folic acid for everyone, now, J. Nutr. 126

(1996) 751S-755S.

[70] Wickramasinghe, S.N. and S. Fida, Bone marrow cells from vitamin B12- and folate-deficient patients misincorporate uracil into DNA, Blood 83 (1994) 1656-1661.

[71] Fenech, M.F., I.E. Dreosti and J.R. Rinaldi, Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men, Carcinogenesis 18 (1997) 1329-1336.

[72] Zhang, J.Z., S.M. Henning and M.E. Swendseid, Poly(ADP-ribose) polymerase activity and DNA strand breaks are affected in tissues of niacin-deficient rats., J. Nutr. 123 (1993) 1349-55.

[73] Jacobson, E.L., Niacin deficiency and cancer in women, J. Am. Coll. Nutr. 12 (1993) 412-416.

[74] Colburn, T., D. Dumanoski and J.P. Myers, Our Stolen Future: Are we Threatening our Fertility, Intelligence, and Survival?: A Scientific Detective Story., Dutton, New York, 1996.

[75] Safe, S.H., Dietary and environmental estrogens and antiestrogens and their possible role in human disease, Environ. Sci. Pollution Res. 1 (1994) 29-33.

[76] Safe, S.H., Environmental and dietary estrogens and human health: Is there a problem?, Environ. Health Perspect. 103 (1995) 346-351.

[77] Safe, S.H., Is there an association between exposure to environmental estrogens and breast cancer?, Environ. Health Perspect. 105 (1997) (Suppl 3): 675-678.

[78] Reinli, K. and G. Block, Phytoestrogen content of foods -- A compendium of literature values, Nutr. Cancer 26 (1996) 1996.

[79] Heinze, J., Interregional differences undermine sperm trend conclusions [letter], Environ Health Perspect 106 (1998) A369-370; discussion A370-1.

[80] Orejuela, F., L.I. Lipshultz and D.J. Lamb, Debate about sperm count decline [letter], Environ Health Perspect 106 (1998) A370; discussion A370-1.

[81] Swan, S.H., E. Elkin and L. Fenster, A reanalysis of sperm density data [response], Environ Health Perspect 106 (1998) A371; discussion A370-1.

[82] Hahn, R.W. (Ed.) Risks, Costs, and Lives Saved: Getting Better Results from Regulation, Oxford University Press and AEI Press, New York and Washington, DC, 1996.

[83] Graham, J. and J. Wiener (Eds.), Risk versus Risk: Tradeoffs in Protecting Health and the Environment, Harvard University Press, Cambridge, Massachusetts, 1995.

[84] U.S. Environmental Protection Agency, Environmental Investments: The Cost of a Clean Environment, Office of the Administrator, Washington, D. C., 1991.

[85] Tengs, T.O., M.E. Adams, J.S. Pliskin, D.G. Safran, J.E. Siegel, M.C. Weinstein and J.D. Graham, Five-hundred life-saving interventions and their cost-effectiveness, Risk Anal. 15 (1995) 369-389.

[86] Plenty of gloom: environmental scares -- forecasters of scarcity and doom are not only invariably wrong, they think that being wrong proves them right, The Economist, 1997, pp. 19-21.

[87] Wildavsky, A.B., But is it True?: A Citizen's Guide to Environmental Health and Safety, Harvard University Press, Cambridge, MA, 1995.

[88] Ames, B.N. and L.S. Gold, Introduction [Foreword], in: H. Marquardt and S. Schafer (Eds.), Toxicology, Academic Press, San Diego, 1999, pp. 1-7.

[89] Ames, B.N. and L.S. Gold, Environmental pollution, pesticides, and the prevention of cancer: Misconceptions, FASEB J. 11 (1997) 1041-1052.

[90] Innes, J.R.M., B.M. Ulland, M.G. Valerio, L. Petrucelli, L. Fishbein, E.R. Hart, A.J. Pallota, R.R. Bates, H.L. Falk, J.J. Gart, M. Klein, I. Mitchell and J. Peters, Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: A preliminary note, J. Natl. Cancer Inst. 42 (1969) 1101-1114.

[91] Davies, T.S. and A. Monro, Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents, J. Am. Coll. Toxicol. 14 (1995) 90-107.

[92] Contrera, J., A. Jacobs and J. DeGeorge, Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals, Regul. Toxicol. Pharmacol. 25 (1997) 130-145.